Cargando…
Hexamethylene amiloride binds the SARS‐CoV‐2 envelope protein at the protein–lipid interface
The SARS‐CoV‐2 envelope (E) protein forms a five‐helix bundle in lipid bilayers whose cation‐conducting activity is associated with the inflammatory response and respiratory distress symptoms of COVID‐19. E channel activity is inhibited by the drug 5‐(N,N‐hexamethylene) amiloride (HMA). However, the...
Autores principales: | Somberg, Noah H., Medeiros‐Silva, João, Jo, Hyunil, Wang, Jun, DeGrado, William F., Hong, Mei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons, Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10503410/ https://www.ncbi.nlm.nih.gov/pubmed/37632140 http://dx.doi.org/10.1002/pro.4755 |
Ejemplares similares
-
Antifungal activity of 6-substituted amiloride and hexamethylene amiloride (HMA) analogs
por: Vu, Kiem, et al.
Publicado: (2023) -
Hexamethylene amiloride blocks E protein ion channels and inhibits coronavirus replication
por: Wilson, Lauren, et al.
Publicado: (2006) -
In Silico Evaluation of Hexamethylene Amiloride Derivatives as Potential Luminal Inhibitors of SARS-CoV-2 E Protein
por: Jalily, Pouria H., et al.
Publicado: (2022) -
Interactions of SARS-CoV-2 envelope protein with amilorides correlate with antiviral activity
por: Park, Sang Ho, et al.
Publicado: (2021) -
6-Furopyridine Hexamethylene Amiloride Is a Non-Selective P2X7 Receptor Antagonist
por: Cuthbertson, Peter, et al.
Publicado: (2022)